The quantification of soluble biomarkers, including chemokines and cytokines, in plasma or serum is an essential component of immuno-oncology research. Luminex technology has long been at the forefront of these endeavors. Luminex assays have been used to advance the understanding of how drugs affect the immune system, discover new biomarkers, and predict clinical responses to different treatment. In this webinar, Mariano Severgnini, a scientist at Dana-Farber, will discuss his work with cancer immunotherapies and his experiences using Luminex technologies for the simultaneous detection of a variety of biomarkers.
You will learn about:
- Important immuno-oncology biomarkers
- Clinical applications of Multiplex technologies
- New approach to Luminex beads assays
Who should attend:
- Cancer researchers
- Drug discovery scientists
- Translational researchers
- Anyone involved in biomarker detection